Topics cover state-of-the-art application of biomarkers in the following clinical categories:
• Current standards/guidelines in the prediction, diagnosis and management of cardiovascular diseases and related conditions.
• Highly sensitive troponin testing and the continued evolution of this biomarker in diagnosing and managing acute myocardial infarction (MI), including type 1 and type 2 MI and other cardiovascular conditions.
• Use of biomarkers as key components of precision medicine in cardiovascular diseases.
• Evidence-based biomarker data in the peer reviewed literature in cardiovascular, diabetes, renal, pulmonary and related diseases.
• The application of biomarkers in therapeutic and device trials as qualification criteria, surrogate endpoints, etc.
• Case studies involving biomarkers as one component in the care of patients with cardiovascular conditions.
